By group, procedural success and freedom from LVOT obstruction (LVOT mean gradient > 50 mm Hg), the primary efficacy endpoint ...

Edwards Lifesciences VP of Engineering Darshin Patel discusses the first-of-its-kind Sapien M3 TMVR system’s design, development and lessons for other medical device developers. Edwards Lifesciences ...

Shortness of breath is one of the most common side effects after open-heart surgery. It can last for weeks or months, but symptoms typically improve over time. Open heart surgery can restore your ...

The purpose of this communication is to describe 39 patients with proved rupture of the mitral chordae tendineae, 24 of whom have been seen at the Massachusetts General Hospital since January 1, 1964 ...

Nitinol is commonly used in replacement heart valve frames, but that’s not how the new Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system uses nitinol’s shape memory ...

Mitral valve regurgitation is a common disease, traditionally treated with valve repair or replacement using open cardiac surgery. The most common etiologies of mitral regurgitation (MR ...

The condition is more common in women and younger patients with valve disorder and can, in the worst case, lead to sudden cardiac arrest. Mitral annular disjunction, MAD, is a heart abnormality in ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

Over the last several decades, the incidence of severe MR owing to leaflet rupture remains unchanged and up to 2% of patients may require urgent mitral valve (MV) replacement (1, 6). As patients with ...